Participate in a clinical study of a potential treatment for Nonalcoholic steatohepatitis (NASH)

two, 2-night stays nights
7 visits

Purpose: to evaluate the safety and tolerability of an investigational medication that would work by increasing the percentage of sugars and fats that is consumed instead of stored in the liver.

There is one screening appointment, prior to two, 2 nights stays and PCR COVID testing

There is 7 outpatient visits

This study also includes 1 eye exams.

Reimbursement for study participation will be provided for time and travel of up to $5,380

We have worked with this investigational medication in previous clinical trials at Nucleus Network.

This study has been reviewed and approved by an independent ethics committee

Call 612-315-6490 to discuss your eligibility today!


Age: 18 to 55
BMI: 28-45 kg/m2
Medications: You will be asked about your current health status and about your medical history, including all medications, over-the-counter products, supplements, and herbal medications that you have been, and are currently taking.
Compensation: Up to $5,380
Smoking: You should not smoke or vape more than 5 cigarettes (or equivalent nicotine product) per week cannot smoke or vape during the confinement period.